Literature DB >> 8885060

Microbial causes of ventilator-associated pneumonia.

J Rello1, A Torres.   

Abstract

Aspiration of microorganisms colonizing the oropharynx is the main route of bacterial entry to lower airways in mechanically ventilated patients. Examination of the microbial flora involved in ventilator-associated pneumonia shows that only few species, among the many oropharynx microorganisms, are responsible for the majority of lower respiratory tract colonizations and infections in intubated patients. Underlying disease, length of intubation, and type and duration of prior antibiotic therapy are the most important factors related with the causative flora of respiratory infections in these patients. Except in certain populations (eg, chronic obstructive pulmonary disease [COPD] patients who may be colonized by Pseudomonas aeruginosa), methicillin-sensitive Staphylococcus aureus, Streptococcus pneumoniae, and unencapsulated Hemophilus influenzae are the predominant respiratory pathogens within the first week of intubation in critically ill patients. These microorganisms are subsequently replaced by multiresistant flora, such as Pseudomonas aeruginosa, methicillin-resistant staphylococci or Acinetobacter baumanii. This change of flora takes place as a consequence of prior antibiotic therapy among other factors. Fungi have to be taken in account particularly in the presence of severe immunodepression. All of these multiresistant pathogens (particularly P aeruginosa) are responsible for most of the deaths directly related to pneumonia; therefore, the early recognition of causative agents and appropriate antibiotic therapy are of great importance determining outcome. This strategy represents the most efficient approach to managing patients with ventilator-associated pneumonia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885060

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  11 in total

1.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

2.  Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors.

Authors:  Ignacio Martin-Loeches; Maria Deja; Despoina Koulenti; George Dimopoulos; Brian Marsh; Antonio Torres; Michael S Niederman; Jordi Rello
Journal:  Intensive Care Med       Date:  2013-01-29       Impact factor: 17.440

Review 3.  Antibacterial treatment of invasive mechanical ventilation-associated pneumonia.

Authors:  F Barcenilla; E Gascó; J Rello; L Alvarez-Rocha
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".

Authors:  Alberto Sandiumenge; Emili Diaz; Maria Bodí; Jordi Rello
Journal:  Intensive Care Med       Date:  2003-04-02       Impact factor: 17.440

5.  Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System).

Authors:  Christine Geffers; Petra Gastmeier
Journal:  Dtsch Arztebl Int       Date:  2011-02-11       Impact factor: 5.594

6.  Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset.

Authors:  J Vallés; A Pobo; O García-Esquirol; D Mariscal; J Real; R Fernández
Journal:  Intensive Care Med       Date:  2007-06-09       Impact factor: 17.440

7.  Ventilator associated pneumonia and infection control.

Authors:  Emine Alp; Andreas Voss
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-04-06       Impact factor: 3.944

Review 8.  Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia.

Authors:  Jordi Rello
Journal:  Crit Care       Date:  2004-11-30       Impact factor: 9.097

Review 9.  Guidelines for the Evaluation and Treatment of Pneumonia.

Authors:  Samuel N Grief; Julie K Loza
Journal:  Prim Care       Date:  2018-09       Impact factor: 2.907

10.  Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study.

Authors:  Emine Alp; Muhammet Güven; Orhan Yildiz; Bilgehan Aygen; Andreas Voss; Mehmet Doganay
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-09-15       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.